11/14/2024 5:40 AM | Immunocore (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/08/2024 3:20 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 9:52 AM | Immunocore (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024 6:22 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 6:00 AM | Immunocore (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/16/2024 5:46 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 12:49 PM | Immunocore (Subject) T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G | |
|
08/29/2024 6:21 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:21 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:06 AM | Immunocore (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/30/2024 4:22 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 3:43 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/29/2024 3:46 PM | Immunocore (Issuer) KRISHANA RANJEEV (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/28/2024 3:17 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 3:15 PM | Bell John Irving (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:15 PM | Herbst Roy Steven (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:15 PM | Immunocore (Issuer) Peterson Kristine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:15 PM | Immunocore (Issuer) Ratcliffe Peter John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 3:50 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:13 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:00 AM | Immunocore (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024 3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024 3:35 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024 3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024 11:36 AM | Immunocore (Subject) St Leger Tina Amber (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024 7:55 PM | Immunocore (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Immunocore (Subject)
| Form SC 13G | |
03/07/2024 8:45 PM | GENERAL ATLANTIC, L.P. (Filed by) Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024 3:15 PM | Berman David M (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:19 PM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:33 AM | Immunocore (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/26/2024 5:46 PM | Berman David M (Reporting) Immunocore (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 3:15 PM | Immunocore (Issuer) Jallal Bahija (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:15 PM | GOLL JOHN (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:15 PM | Berman David M (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:15 PM | Di Donato Brian (Reporting) Immunocore (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:16 PM | Immunocore (Issuer) St Leger Tina Amber (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:57 AM | Immunocore (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024 10:00 AM | Immunocore (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
02/01/2024 4:25 PM | BAKER BROS. ADVISORS LP (Filed by) Immunocore (Subject)
| Form SC 13D/A | |
01/05/2024 3:17 PM | Immunocore (Issuer) St Leger Tina Amber (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 6:19 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:55 PM | Immunocore (Subject) St Leger Tina Amber (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:51 PM | Immunocore (Issuer) Jallal Bahija (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:52 PM | Immunocore (Issuer) Kaul Siddharth (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:53 PM | Immunocore (Issuer) PEREZ ROBERT J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:54 PM | Immunocore (Issuer) Peterson Kristine (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:55 PM | Immunocore (Issuer) Ratcliffe Peter John (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:57 PM | Immunocore (Issuer) St Leger Tina Amber (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:41 PM | Di Donato Brian (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:42 PM | Bell John Irving (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:43 PM | Berman David M (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:45 PM | Coy Travis Alan (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:47 PM | GOLL JOHN (Reporting) Immunocore (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 5:25 AM | Immunocore (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 4:30 PM | Immunocore (Subject) Jallal Bahija (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 12:54 PM | Immunocore (Subject) St Leger Tina Amber (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023 7:33 PM | Berman David M (Reporting) Immunocore (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |